Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients

Journal of the National Cancer Institute

Volumn 88, Issue 12, 1996, Pages 802-811

  Shamanin, Vladimir ^a   Zur Hausen, Harald ^a   Lavergne, Donna ^a   Proby, Charlotte M ^b   Leigh, Irene M ^b   Neumann, Christine ^c   Hamm, Henning ^d   Goos, Manfred ^e   Haustein, Uwe Frithjof ^f   Jung, Ernst G ^g   Plewig, Gerd ^h   Wolff, Helmut ⁱ   De Villiers, Ethel Michele ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g Hautklinik   (Germany)

^h UNIVERSITY OF MUNICH   (Germany)

ⁱ UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATION; SKIN CANCER; VIRUS CARCINOGENESIS; WART VIRUS;

AMINO ACID SEQUENCE; CARCINOMA IN SITU; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; HUMANS; IMMUNOCOMPROMISED HOST; KERATOACANTHOMA; KIDNEY TRANSPLANTATION; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TUMOR VIRUS INFECTIONS; WARTS;

EID: 15844386535     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.12.802     Document Type: Article

References (42)

1. Preston DS, Stern RS. Nonmelanoma cancers of the skin [see comment citation in Medline], N Engl J Med 1992;327:1649-62.
2. Rees J. Genetic alterations in non-melanoma skin cancer. J invest Dermatol 1994;103:747-50.
3. Ko CB, Walton S, Keczkes K, Bury HP, Nicholson C. The emerging epidemic of skin cancer [see comment citation in Medline]. Br J Dermatol 1994;130:269-72.
4. Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol 1994;131:455-64.
5. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 1993;90:4216-20.
6. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994;186:131-56.
7. zur Hausen H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 1994;343:955-7.
8. Orth G. Epidermodysplasia verruciformis. In: Salzman NP, Howley PM, editors. The Papovaviridae. Vol 2. The papillomaviruses. New York: Plenum Press. 1987:199-243.
9. Purdie KJ, Sexton CJ, Proby CM, Glover MT, Williams AT, Stables JN, et al. Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus. Cancer Res 1993;53:5328-33.
10. Stark LA, Arends MJ, McLaren KM, Benton EC, Shahidullah H, Hunter JA, et al. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer 1994;69:222-9.
11. Shamanin V, Glover M, Rausch C, Proby C, Leigh IM, zur Hausen H, et al. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 1994;54:4610-3.
12. Berkhout RJ, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995;33:690-5.
13. Kawashima M, Favre M, Obalek S, Jablonska S, Orth G. Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomaviruses. J Invest Dermatol 1990;95:537-42.
14. Egawa K, Delius H, Matsukura T, Kawashima M, de Villiers EM. Two novel types of human papillomavirus. HPV 63 and HPV 65: comparisons of their clinical and histological features and DNA sequences to other HPV types. Virology 1993;194:789-99.
15. Shamanin V, Delius H, de Villiers EM. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 1994;75:1149-56.
16. Obalek S, Favre M, Szymanczyk J, Misiewicz J, Jablonska S, Orth G. Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients. J Invest Dermatol 1992;98:936-41.
17. Euvrard S, Chardonnet Y, Pouteil-Noble C, Kanitakis J, Chignol MC, Thivolet J, et al. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer 1993;72:2198-206.
18. Trenfield K, Salmond CA, Pope JH, Hardie IR. Southern blot analysis of skin biopsies for human papillomavirus DNA: renal allograft recipients in south-eastern Queensland. Australas J Dermatol 1993;4:71-8.
19. Tieben LM, Berkhout RJ, Smits HL, Bouwes Bavinck JN, Vermeer BJ, Bruijn JA, et al. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol 1994;131:226-30.
20. Hirt L, Hirsch-Behnam A, de Villiers EM. Nucleotide sequence of human papillomavirus (HPV) type 41: an unusual HPV type without a typical E2 binding site consensus sequence. Virus Res 1991;18:179-89.
21. Matsukura T, Iwasaki T, Kawashima M. Molecular cloning of a novel human papillomavirus (type 60) from a plantar cyst with characteristic pathological changes. Virology 1992;190:561-4.
22. Egawa K. New types of human papillomaviruses and intracytoplasmic inclusion bodies: a classification of inclusion warts according to clinical features, histology and associated HPV types. Br J Dermatol 1994;130: 158-66.
23. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 1983; 80:3812-5.
24. Favre M, Kremsdorf D, Jablonska S, Obalek S, Pehau-Amaudet G, Croissant O, et al. Two new human papillomavirus types (HPV54 and 55) characterized from genital tumours illustrate the plurality of genital HPVs. Int J Cancer 1990;45:40-6.
25. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group [see comment citation in Medline]. J Natl Cancer Inst 1995;87:796-802.
26. Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer 1995;61:13-22.
27. Kuhnl-Petzold C, Grosser A, de Villiers EM. HPV 16 assozierter bowenoid-verrucösser Tumor der palmaren Haut. Akt Dermatol 1988;14: 848-9.
28. Sau P, McMarlin SL, Sperling LC, Katz R. Bowen's disease of the nail bed and periungual area. A clinicopathologic analysis of seven cases. Arch Dermatol 1994;130:204-9.
29. Gissmann L, Pfister H, zur Hausen H. Human papilloma viruses (HPV): characterization of four different isolates. Virology 1977;76:569-80.
30. Jablonska S, Obalek S. Favre M, Golebiowska A, Croissant O, Orth G. The morphology of butchers' warts as related to papillomavirus types. Arch Dermatol Res 1987;279 Suppl:66-72.
31. de Villiers EM. Prevalence of HPV 7 papillomas in the oral mucosa and facial skin of patients with human immunodeficiency virus [letter]. Arch Dermatol 1989;125:1590.
32. zur Hausen H. Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events. Lancet 1986;2:1370-2.
33. de Villiers EM. Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol 1994;186:1-12.
34. Kawashima M, Jablonska S, Favre M, Obalek S, Croissant O, Orth G. Characterization of a new type of human papillomavirus found in a lesion of Bowen's disease of the skin. J Virol 1986;57:688-92.
35. Beaudenon S, Kremsdorf D, Obalek S, Jablonska S, Pehau-Arnaudet G, Croissant O, et al. Plurality of genital human papillomaviruses: characterization of two new types with distinct biological properties. Virology 1987;161:374-84.
36. de Villiers EM. Papilloma viruses in cancers and papillomas of the aerodigestive tract. Biomed Pharmacother 1989;43:31-6.
37. Nuovo GJ, Crum CP, de Villiers EM, Levine RU, Silverstein SJ. Isolation of a novel human papillomavirus (type 51) from a cervical condyloma. J Virol 1988;62:1452-5.
38. Penn I. Post-transplant kidney cancers and skin cancers (including Kaposi's sarcoma). In: Schmahl D, Penn I, editors. Cancer in organ transplant recipients. Berlin: Springer-Verlag, 1991:46-53.
39. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990;49:506-9.
40. Green A. Changing patterns in incidence of non-melanoma skin cancer. Epithelial Cell Biol 1992;1:47-51.
41. Ho GY, Burk RD, Fleming I, Klein RS. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994;56:788-92.
42. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.